Cerebellar dysfunction following dextropropoxyphene-induced carbamazepine toxicity
Sir, The interaction between dextropropoxyphene and carbamazepine was reported in the Postgraduate Medical Journal by Yu et al. ' There are few case reports of this interaction despite the widespread use of both drugs, in clinical practice. The following case report is interesting not only in the dramatic nature of the interaction but also in the presentation of the toxic state.
A 24 year old man had been on long-term carbamazepine therapy for epilepsy and had been prescribed dextropropoxyphene for an ear infection. He presented with an acute onset of slurred speech, incoordination, marked intention tremor, multidirectional nystagmus and ataxia such that the patient could hardly stand. He had taken a total of eight tablets of coproxamol (dextropropoxyphene 32.5 mg/paracetamol 325 mg) over the preceding 24 hours.
An urgent carbamazepine level showed a dramatic four-fold increase in the serum carbamazepine concentration, which was previously within the normal range.
The patient's signs and symptoms rapidly resolved following 48 hours cessation of the carbamazepine until normal serum levels were achieved. Skeletal X-ray films were normal. Despite rehydration, total serum calcium reached 4.65 mmol/l. Calcitonin, steroids and intravenous biphosphonates were initiated, but no response was observed.
As neck ultrasound disclosed a round-shaped lesion, exploratory surgery was performed. A normal thyroid and scattered lymph nodes were found along the internal jugular chain. Biopsy of three parathyroids showed no abnormalities. Histological examination of one lymph node revealed metastasis of undifferentiated carcinoma. After surgery, hypercalcaemia persisted refractory to treatment and the patient finally died. Necropsy revealed a SCCE of the distal portion of the oesophagus, and metastasis to bone, liver and lungs.
PTHrp plays an important role in the humoral hypercalcaemia ofmalignancy of SCCE. Tachimori et al. 3 
